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Vero cells have been used successfully in Toxoplasma gondii maintenance. Medium supplementation for
culture cells with fetal bovine serum is necessary for cellular growth. However, serum in these cultures
presents disadvantages, such as the potential to induce hypersensitivity, variability of serum batches,
possible presence of contaminants, and the high cost of good quality serum. Culture media formulated
without any animal derived components, designed for serum-free growth of cell lines have been used
successfully for different virus replication. The advantages of protozoan parasite growth in cell line cul-
tures using serum-free medium remain poorly studied. Thus, this study was designed to determine
whether T. gondii tachyzoites grown in Vero cell cultures in serum-free medium, after many passages,
are able to maintain the same antigenic proprieties as those maintained in experimental mice. The stan-
dardization of Vero cell culture in serum-free medium for in vitro T. gondii tachyzoite production was per-
formed establishing the optimal initial cell concentration for the conﬂuent monolayer formation, which
was 1  106 Vero cell culture as initial inoculum. The total conﬂuent monolayer formatted after 96 h and
the best amount of harvested tachyzoites was 2.1107 using parasite inoculum of 1.5  106 after 7 days
post-infection. The infectivity of tachyzoites released from Vero cells maintained in serum-free medium
was evaluated using groups of Swiss mice infected with cell-culture tachyzoites. The parasite concentra-
tions were similar to those for mice infected with tachyzoites collected from other infected mice. The
data from both in vivo and in vitro experiments showed that in at least 30 culture cell passages, the par-
asites maintained the same infectivity as maintained in vivo. Another question was to know whether in
the several continued passages, immunogenic progressive loss could occur. The nucleotide sequences
studied were the same between the different passages, which could mean no change in their viability
in the lysate antigen. Thus, the antigen production by cell culture has clear ethical and cost-saving advan-
tages. Moreover, the use of culture media formulated without any human or animal derived components,
designed for serum-free growth of cell lines, successfully produced tachyzoites especially for antigen
production.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Toxoplasma gondii is an obligate intracellular protozoan parasite
capable of infecting humans, warm-blooded domestic and wild
animals. It is geographically widespread, and is thought to infect
approximately one-third of the world’s human population,
although the prevalence of the parasite varies from country to
country (Dubey, 1998; Tenter et al., 2000; Bojar and Szyman´ska,
2010; Elmore et al., 2010).arasitologia, Instituto Adolfo
Paulo, SP, Brazil. Fax: +55 11
a-Chioccola).
sevier OA license.The laboratorial diagnosis of toxoplasmosis is based on serolog-
ical and molecular methods, and rarely, on the isolation of T. gondii
(Ahn et al., 1997; Pereira-Chioccola et al., 2009). Thus, the use of
in vivo or in vitro tachyzoites is essential for different procedures
such as experimental models, genetic studies and antigen produc-
tion (Sibley and Boothroyd, 1992; Roos et al., 1994; Chatterton
et al., 2002; Buddhirongawatr et al., 2006).
The RH strain has been used routinely in the majority of T. gon-
dii studies. From the ﬁrst isolation, from an infected human tissue
in 1939 (Sabin, 1941), this strain has been maintained in vivo and
in vitro by continuous passage in either mouse peritoneal cavities
or in cultured cells (Mavin et al., 2004).
The most common antigen used in immunological assays is a ly-
sate of T. gondii tachyzoites from the RH strain, which has been
maintained via intraperitoneal passages in mice (Lee et al., 2008;
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tion via mouse passages is considered an expensive method since
mice survive only 4–6 days after infection, yet tachyzoite suspen-
sions normally contain large numbers of mouse peritoneal cells.
Additionally, the development of these procedures requires an
extensive infrastructure for antigen production such as a vivarium,
specialized professionals, and a great deal of animals. Thus, the
propagation of tachyzoites in cell culture is more economical.
Since in vitro culture of T. gondii has been possible for many
years, a variety of cell lines and culture methods have been devel-
oped to produce antigens for: immunological tests (Warren and
Russ, 1948; Verhofstede et al., 1988; Hass and Aspock, 1990;
Ashburn et al., 2000; Meira et al., 2008), parasite isolation (Derouin
et al., 1987; Calico et al., 1991; Domzig et al., 1993; Diab and El-
Bahy, 2008), therapeutic (Bunetel et al., 1995; Fichera et al.,
1995; Fichera and Roos, 1997) and vaccination studies (Garcia
et al., 2005; Costa-Silva et al., 2008; Xue et al., 2008).
Typically there are two fundamental reasons for doing parasite
cultivation in vitro. The ﬁrst is that it provides long-term preserva-
tion of strains without having to resort to laboratory mammals.
The second is the cheap production of a large number of parasite
cells, especially for applications such as antigens, since it is possi-
ble to produce a large quantity of pure, extra-cellular, or recovered
intact parasites. The goal of a mass production technique is usually
rapid growth of intact tachyzoites. However, small amounts of host
cell remnants such as serum proteins, and long-term maintenance
of strains and regular provision of fresh viable tachyzoites still re-
lies on culture in animals, usually rats or mice. In addition, cur-
rently, cell culture systems are replacing animal models because
of ethical issues, infrastructural deﬁciencies such as the lack of
experienced personnel and/or standardized vivariums in most re-
search centers. In addition, the cost of in vitro culture is one-third
to one-half of the cost of animal culture, which could justify the
use of this system in routine procedures (Harmer et al., 1996;
Evans et al., 1999; Ashburn et al., 2000; Chatterton et al., 2002).
Among the different cell lines, Vero cells have been used suc-
cessfully in T. gondii maintenance (Costa-Silva et al., 2008; Saadat-
nia et al., 2010). Originally, Vero cells were established in Japan
from the kidney of a normal adult African green monkey (Cercopi-
thecus aethiops). Previous studies showed that Vero cell lines were
free of oncogenic properties, not presenting risks to humans when
used as substrate in the production of vaccines (Furesz et al., 1989).
These cells have been used extensively for production of human
virus vaccines in large-scale production as microcarriers or cul-
tures in bioreactors. These procedures have also been recognized
by the WHO (Frazatti-Gallina et al., 2004).
Medium supplementation for culture cells with fetal bovine ser-
um, human or bovine albumin is necessary for cellular growth.
However, the use of serum in culture presents disadvantages, such
as the potential to induce hypersensitivity, variability of serum
batches, possible presence of contaminants (bacteria, fungi, myco-
plasma, bovine viruses, etc.), and the high cost of a good quality
serum (Fishbein et al., 1993; Froud, 1999; Frazatti-Gallina et al.,
2004). Previous studies showed that culture media formulated
without human or animal derived components (VP-SFM AGT med-
ium – GIBCO), designed for serum-free growth of cell lines have
been used successfully for different virus replications, such as ra-
bies virus, Japanese encephalitis virus, yellow fever virus and oth-
ers (Frazatti-Gallina et al., 2004; Toriniwa and Komiya, 2011;
Monath et al., 2011).
Previous studies of our group showed, even after culture cell
washing with medium without fetal bovine serum before tachyzo-
ite infection, serum traces were still detected in polyacrylamide gel
(Meira et al., 2008; Costa-Silva et al., 2008). Although, a previous
study demonstrated that recovery of tachyzoites is slightly lower
in the absence of fetal calf sera (Diab and El-Bahy, 2008), theadvantages of using T. gondii growth in cell line cultures using ser-
um-free medium were not totally established. Thus, the present
study was designed to determine whether tachyzoites grown in
Vero cell cultures in medium serum-free, after many passages
are able to maintain the same antigenic proprieties as those main-
tained in experimental mice.2. Materials and methods
2.1. Mice, cell cultures and T. gondii strain
Four-week-old female Swiss mice were used in experiments
and to maintain T. gondii (RH strain) experiments. Groups of four
mice were selected for in vivo infectivity experiments. All mice
used in these experiments were housed in the pathogen-free
mouse colony and obtained from the Laboratory Animal Center
of Instituto Adolfo Lutz. During the experiments, the mice
were equally maintained in the Laboratory Animal Center in
Experimentation.
Vero cell monolayers (ATCC-CCL-81) obtained from the working
Vero cell bank (WCB) from Rabies Laboratory (Instituto Butantan –
SP-Brazil) were used in this study. This WCB was prepared with
Vero cells maintained in serum-free medium and were tested
according WHO requirements for cell lines: tests to determine
the absence of fungi, bacteria, mycoplasma and other adventitious
agents. To maintain the Vero cells in 25 cm2 T-ﬂasks, serum-free
medium (VP SFM AGT-Gibco-Life Technologies) supplemented
with 4 mM of L-glutamine and 2.5 lg/mL of gentamicin was used.
The Vero cells in the T-ﬂasks were washed once with PBS, incu-
bated with 0.25% trypsin (Life Technologies) for 5 min at room
temperature and tapped sharply to release the cells from the bot-
tom of the ﬂasks. Subsequently a new medium aliquot was added
to the trypsinized cells. The cells were counted with a haemocy-
tometer. An appropriate amount of cells were subcultured every
3–4 days into new ﬂasks with medium and then incubated at
37 C, in 5% CO2 atmosphere to form the conﬂuent monolayer.
T. gondii RH tachyzoites were grown and maintained in Swiss
mice ascites by intraperitonial inoculation or in Vero cells. Every
3 or 4 days after infection, the peritoneal ﬂuids from infected mice
were collected in phosphate-buffered saline, pH 7.2 (PBS), pooled
and centrifuged at 3000g for 10 min. Tachyzoites from both mice
and cell cultures were washed twice, counted, suspended in PBS,
at different concentrations for infecting other cell cultures or
groups of mice. The same procedure was followed to prepare anti-
gens for ELISA or the other experiments. This study was performed
according recommendations of the ‘‘Colegio Brasileiro de Experi-
mentaçao Animal’’ (COBEA), and the institutional review board of
the Ethics Committee of both institutions approved this study.
2.2. Study of Vero cell growth in T-ﬂask to T. gondii production in vitro
Different Vero cell concentrations of 1  105, 5  105, 1  106
and 5  106 cells per 25-cm2 T-ﬂasks were used. Two T-ﬂasks of
each cell concentration were incubated with 5 mL serum free med-
ium at 37 C in 5% CO2 atmosphere. The amount of cells/ﬂask after
24, 48, 72, 96 and 120 h were determined using an inverted micro-
scope until forming a complete conﬂuent monolayer (100%). The
results were expressed in percent of conﬂuent monolayer.
2.3. In vitro and in vivo T. gondii infectivity
T. gondii production was tested after establishing the optimal
Vero cell concentration/T-ﬂask and the best time of incubation.
Six 25 cm2 T-ﬂask (with initial inoculum of 1  106 Vero cells)
were infected, after 96 h, with 7  105, 1.5  106 and 3  106
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volume of each T-ﬂask was 5 mL of new VP SFM AGT medium ali-
quot. These parasites were harvested from previously infected
Swiss mice peritoneums. The cultures were incubated at 37 C in
5% CO2 atmosphere. The release parasites in supernatants were
counted daily with a hemocytometer for 10 days.
Next, tachyzoites released from Vero cells in VP SFM AGT med-
ium were maintained for 30 passages. Each ﬁve passages (1st, 5th,
10th, 15th, 20th, 25th and 30th), parasites were collected to infect
another two new T-ﬂasks with intention to evaluate in vitro and
in vivo infectivity as well as, antigen production.
To compare the infectivity of parasites released from Vero cells
in VP SFM AGT medium and Swiss mice, both sources of tachyzo-
ites were used to infect eight Swiss mice divided in four groups.
Cell culture tachyzoites (collected at 1st, 5th, 10th, 15th, 20th,
25th and 30th passages) were used to infect four mice that were
divided in two Groups (1A and 1B). Group 1A received 1  105
tachyzoites/animal and Group 1B, 1  106 tachyzoites/animal.
Two control groups (2A and 2B) received the same scheme of infec-
tion using tachyzoites collected from another group of mice. After
4 days, peritoneal ﬂuid was collected from each mouse, and the
infection levels were evaluated by parasite counts in a hemocy-
tometer. These experiments were done twice to conﬁrm the results
(two independent experiments).
2.4. DNA puriﬁcation, PCR, primer selection and sequencing
Tachyzoites (1  107 parasites/mL) obtained in each ﬁve pas-
sages in Vero cell culture were used for DNA extraction by PureLink
Genomic DNA Kits (Qiagen), according to the manufacturer’s
instructions. DNA pellets were dissolved in ultra-pure water.
DNA concentrations and purity were determined by the ratio of
O.D. at 260 and 280 nm in a NanoDrop ND100 (Thermo Scientiﬁc).
The experiments for PCR and sequencing were made using the two
primer sets. The ﬁrst was a SAG2 F4/R4 marker (50GCTACCT-
CGAACAGGAACAC30 and 50GCATCAACAGTCTTCGTTGC30), which
ampliﬁed a product around 300-bp from the 50 end side of SAG2
gene located in T. gondii chromosome VIII. The second was a
SAG2F2/R2 marker (50ATTCTCATGCCTCCGCTTC30 and 50AACGTTT-
CACGAAGGCACAC30), which ampliﬁed a 240-bp product from an-
other side (30end) of the SAG2 gene (Howe et al., 1997; Khan
et al., 2007).
Each PCR was carried out in a LongGene Thermal Cycler in a ﬁ-
nal volume of 25 ll. The DNA samples (2 ll) and 15 pmol of each
primer were added to a kit purchased from Promega (Go Taq Green
Master Mix). The PCR mix (12.5 ll) was composed of 1 unit of Taq
DNA polymerase, 10 mM Tris–HCl, pH 8.5; 50 mM KCl; 1.5 mM
MgCl2; and 200 mM of each of each dNTP. The ampliﬁcation runs
contained two negative controls (ultrapure water and a negative
DNA for toxoplasmosis). The thermal cycle conditions were made
by one initial denaturation cycle for 5 min at 95 C, 35 cycles of
denaturation at 94 C for 30 s, annealing at 55 C for 1 min, and
extension at 72 C for 90 s. The procedure was completed by a ﬁnal
cycle extension for 3 min. PCR products were analyzed under UV
illumination after electrophoresis in 2% agarose gel and staining
with ethidium bromide. The images were analyzed by a Mini Bis
Gel Imager and Documentation (BioSystematica). The size of frag-
ments was based on comparison with a 100-bp ladder (Ferreira
et al., 2008).
Each PCR product was used for DNA sequencing after puriﬁca-
tion according to the manufacturer’s instructions (PCR Clean-up
System kit-PROMEGA). The fragments were sequenced with both
primers to obtain forward and reverse sequences for both markers.
The sequencing analysis was done using an ABI Prism BigDye Ter-
minator Cycle Sequencing reaction kit and electrophoresis was
made in an ABI Prism 377 DNA Sequencer (Applied BioSystems,Foster City, CA/USA). The nucleotide sequences were analyzed
and manually assembled and aligned for comparison using a
Bio-Edit Sequence Alignment Editor. The alignments with the Gen-
bank published sequences were made using the ‘‘NCBI/nucleotide–
nucleotide BLAST’’ (http://www.ncbi.nlm.nih.gov/BLAST).2.5. Antigen production and immunological tests
Two different protocols for antigen production were made using
1  107 cell culture tachyzoites/mL in PBS collected at 1st, 5th,
10th, 15th, 20th, 25th and 30th passage in Vero cell culture in ser-
um-free medium. The ﬁrst was the conventional method as previ-
ously described (Costa-Silva et al., 2008; Meira et al., 2008). Brieﬂy,
tachyzoites were sonicated for 10 cycles of 1.0 A/min, for 5 min
with 2 min intervals. In the second protocol, tachyzoites were
lysed using glass beads (SIGMA 150:212 microns) by vortex for
eight cycles per 4 min with 2-min intervals. In procedures, Toxo-
plasma lysate antigen (TLA) was dissolved in 0.3 M NaCl, and the
protein concentration was determined in a Nanodrop ND 100
(Thermo Scientiﬁc). The percentage of tachyzoite lysis of each
batch was calculated after viable parasite counts by microscopy.
Next TLA were evaluated by ELISA using the following serum
groups: (i) 10 sera from chronically infected patients; (ii) 10 sera
from normal individuals without toxoplasmosis; (iii) two pooled
positive sera (ﬁve chronically infected mice with ME-49 strain);
and (iv) two pooled negative sera (ﬁve healthy mice). Reactions
were performed with polystyrene microtiter plates (ﬂat bottom,
low binding, Corning) using TLA at a concentration of 2 lg/mL.
Each plate was incubated overnight at 4 C with the antigen dis-
solved in 0.1 mL of 0.1 M NaHCO3, pH 8.5. Unbound antigens were
removed by washing the plates with PBS, pH 7.2 containing 0.05%
Tween 20. The free binding sites were blocked by treating the wells
with 5% skimmed milk/PBS. After 1 h, 50 ll of each serum sample
diluted 1:50 (mouse sera) and 1:200 (human sera) in 5% skimmed
milk–PBS was incubated for 60 min at 37 C. After ﬁve washes with
PBS–Tween 20, the wells were incubated for a further 60 min at
37 C with a horseradish peroxidase-conjugated goat anti-mouse
(1:4000) and anti-human immunoglobulin G (1:20000) (Sigma) di-
luted in 5% skimmed milk/PBS. After a new wash cycle with PBS–
Tween 20, substrate solution (0.1 M citric acid, 0.2 M Na2HPO4,
0.05% o-phenylenediamine, 0.1% H2O2) was added to each well
and the plates were left to stand at room temperature in the dark
for 30 min. Color development was stopped by adding 50 ll of 4 N
H2SO4. The absorbance was measured with an ELISA reader (Mul-
tiscan; Labsystems) with a 492 nm ﬁlter. The reactions were previ-
ously standardized (Costa-Silva et al., 2008; Meira et al., 2008).
Each serum sample was assayed in duplicate. The absorbance val-
ues were subtracted from the background, and the arithmetic
mean was calculated. The values of each group were represented
by the mean and standard error (SE) of the absorbance of each
serum sample. The reactions were done twice to conﬁrm the
results.2.6. Data analysis
The comparisons between the infectivity from parasites re-
leased from Vero cells and Swiss mice were statistically evaluated
by the computer program GraphPad Prisma 5.0 (San Diego, CA).
Differences between means of number of tachyzoites recovered
per mL of mouse peritoneal ﬂuids of Groups 1A and 2A and 1B
and 2B were tested for signiﬁcance by using the variance analyses,
calculated by F test. The coefﬁcient of similarity between both
groups was calculated by Unpaired Student’s t-test (two-tailed).
Differences or similarities were considered statistically signiﬁcant
when P value was <0.05.
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3.1. Vero cell inoculum and optimization of T. gondii production
in vitro
The standardization of Vero cell culture in serum free medium
for T. gondii tachyzoite production was performed in two stages.
The ﬁrst was to establish the optimal inoculum for the conﬂuent
monolayer formation. Four different concentrations of cell inocu-
lum were tested (1  105, 5  105, 1  106 or 5  106 cells) using
25-cm2 T-ﬂasks and 5 mL of VP SFM AGT medium per T-ﬂask.
The culture cells were evaluated every day. As shown in Table 1,
the best Vero cell initial concentration was 1  106. The total con-
ﬂuent monolayer was formatted after 96 h. The concentration of
5  106 cells as initial inoculum resulted in a rapid cell total conﬂu-
ent monolayer (in 48 h); however, after 72 h an excess of cell con-
ﬂuence and cell death occurred. The excess of host cells hampers
the parasite penetration.
The second step was to establish the optimal T. gondii infection.
Six 25-cm2 T-ﬂasks received 1  106 Vero cells as inoculum and VP
SFM AGT medium. After 96 h, in each two T-ﬂasks, the cells were
infected with 7  105, 1.5  106 and 3  106 tachyzoites in a ﬁnal
volume of 5 mL of new medium aliquot, respectively. The cultures
were incubated at 37 C in 5% CO2 atmosphere. As shown in Table 2,
the best multiplication of harvested tachyzoites was (2.1  107)
using parasite inoculum of 1.5  106 after 7 days post-infection.
However, similar results were also shown after 7 and 8 days
post-infection when inoculums were made with 0.7 or 3.0  106.3.2. Infectivity, in vivo, of tachyzoites from Vero cell culture in serum-
free medium
The infectivity of tachyzoites released from Vero cells main-
tained in VP SMF AGT medium was evaluated during 30 passages.
Two groups of Swiss mice were infected with 1  105 or 1  106
cell culture tachyzoites/animal as described in the Section 2.
Fig. 1 shows the tachyzoite amount per mL of mouse peritoneal
ﬂuid after 4 days post-infection. These experiments were done
each 5-culture tachyzoite passage (Fig. 1A). The control group re-
ceived parasites collected from other infected mice in the same
periods (Fig. 1B).
The results are expressed as mean and standard error (SE) of
two mice per group. The statistical analysis, using the Student’s t
and F tests were done to determine whether infectivity from para-
sites released from Vero cells (Fig. 1A) and Swiss mice (Fig. 1B)
were statistically different. The variance analysis by F test revealed
that results of groups infected with 1  105 parasites, 1A and 2A
(1.348, P = 0.2520) were not statistically different, as well as
Groups 1B and 2B (1.199, P = 0.2538), that received 1  106 para-
sites. Although infectivity variations per group have been observed
during the same period of inoculation, these results showed thatTable 1
Kinetics of Vero cell growth maintained in serum-free medium in 25 cm2 T-ﬂasks
with different initial cell concentration.
Initial Vero cell concentration/25 cm2 T-ﬂasks Percent of cell conﬂuence
in monolayer
Time of incubation
(h) at 37 C
24 48 72 96 120
1  105 20 30 50 60 a
5  105 50 70 80 90 100
1  106 70 90 95 100 100
5  106 80 100 100 a a
a Excess of cell conﬂuence and/or cell death.tachyzoite concentrations recovered in mouse peritoneal ﬂuids
after 4 days post-infection were similar in mice infected with par-
asites cultivated in Vero cells or collected from infected mice.
The data from both in vivo and in vitro experiments showed that
in at least 30 culture cell passages, the parasites maintained the
same infectivity as maintained in vivo.3.3. Tachyzoite genetic and antigenic characteristics after several Vero
cell culture passages
The sequencing experiments were done in order to estimate
whether after different culture passages, parasites maintained
the same genetic homogeneity. Different regions of the SAG2 gene
have been used for T. gondii genotyping studies (Su et al., 2006;
Khan et al., 2007). Thus, two different regions of SAG2 gene were
used here. The sequencing analyses were made in PCR products
ampliﬁed from DNA extracted from tachyzoites collected each ﬁve
Vero cell culture passage. One PCR product was a 300-bp region
from SAG2 gene located near the 50 end side. The second PCR prod-
uct was a 240-pb, located on the opposite side (30 end region).
Firstly, the quality of the experiments was checked comparing
the sequences with others already described in GenBank. The re-
sults conﬁrmed the complete identity for the SAG2 gene and
SAG2 protein. Next, after sequence alignment and as shown
Fig. 2, all samples (1st, 5th, 10th, 15th, 20th, 25th, 30th passage)
presented the same nucleotide sequence. No modiﬁcation was ob-
served during the 30 passages, showing conserved parasite genetic
identity.
Next, the antigenic features were evaluated by ELISA using
well-known immune-sera and TLA as antigen. One additional tach-
yzoite lysis protocol, using glass beads and vortex mixed, was also
tested. The conventional tachyzoite lysis method includes parasite
sonication. As shown in Table 3, parasite lysis using glass beads
and vortex was faster and more efﬁcient than lysis using a
sonicator.
The different TLA batches (coating 2 lg/mL of TLA/glass beads)
were tested in ELISA. The results were shown in Fig. 3. Mouse or
human negative sera for toxoplasmosis had negative results in all
antigen batches (1st to 30th culture passage). In contrast, all anti-
gen batches were able to detect T. gondii speciﬁc IgG antibodies
from both, human or mouse positive sera.4. Discussion
Many centers use T. gondii tachyzoites, derived from cell cul-
tures, as an antigen source in serological diagnostic assays (Hughes
et al., 1986; Ashburn et al., 2000; Chatterton et al., 2002;
Buddhirongawatr et al., 2006). Most use the T. gondii RH strain,
maintained via intraperitoneal passages in mice, for crude antigen
production (Ware and Kasper, 1986; Colombo et al., 2005; Lee
et al., 2008; Macre et al., 2009; Ferreira-da-Silva et al., 2009; Lynch
et al., 2009).
Another alternative is continuous cell cultures, which could
provide regular harvests of fresh viable tachyzoites (Evans et al.,
1999). Continuous cell lines are easy to maintain, reliable and inex-
pensive. T. gondii has been cultured in different continuous cell
lines with a wide variation in the quality and quantity of the pro-
duced tachyzoites. The main cell lines used were HFF (Gail et al.,
2004; Molestina et al., 2008), Hep-2 (Hughes et al., 1986; Diab
and El-Bahy, 2008), Vero (Costa-Silva et al., 2008; Meira et al.,
2008; Diab and El-Bahy, 2008; Saadatnia et al., 2010); and HeLa
(Hughes et al., 1986; Ashburn et al., 2000; Chatterton et al.,
2002; Deg˘irmenci et al., 2011). Optimizing a mass production tech-
nique means balancing factors such as the multiplication rate of
the host cells and parasites, as well as, their generation periods un-
Table 2
Amount of viable tachyzoites obtained from 25-cm2 T-ﬂask supernatants after Vero cell infection with indicated number of T. gondii RH strain.a The results were expressed by
tachyzoite counts in 5 mL of medium obtained during 10 days (average of three 25-cm2 T-ﬂasks). The experiments were done twice.
Amount of tachyzoites added to 25 cm2 T-ﬂasksa Amount of viable tachyzoites released 106/mL (tachyzoite multiplication after initial inoculum)
Days post-infection
1 2 3 4 5 6 7 8 9 10
0.7  106 0 0 0.1 0.2 1.3 11.2 20 20 11 b
1.5  106 0.01 0.05 0.05 0.1 0.5 1.2 21 10 10 b
3.0  106 0.01 0.02 0.08 0.2 0.9 6.2 20 17 b b
b Non-viable parasites.
Fig. 1. In vivo infectivity experiments: number of T. gondii tachyzoites recovered per mL of mouse peritoneal ﬂuids after 4 days post-infection. (A) Groups 1A, black bars; and
1B, white bars received 1  105 and 1  106 tachyzoites/animal, respectively. The parasites were collected from supernatants of Vero cell cultures in serum-free medium. (B)
Control groups, 2A (black bars) and 2B (white bars) received the same data and scheme tachyzoites collected from other infected mice. Tachyzoites from cell cultures were
collected at indicated passages. The values are expressed as mean ± SE of two mice per group. The experiments were done twice at different times and the results were
similar. The Student’s t and F tests revealed that Groups 1A and 2A, as well as, Groups 1B and 2B are statistically similar at P < 0.05.
B
A
Fig. 2. T. gondii, RH strain. Nucleotide sequence from SAG 2 gene located near the 50 end side (A) and on the opposite side, 30 end (B). Multiple sequence alignment analysis of
the PCR products ampliﬁed from DNA extracted from tachyzoites collected at each ﬁve Vero cell culture passages (1st, 5th, 10th, 15th, 20th, 25th and 30th).
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Table 3
TLA production. Comparison of the conventional method using tachyzoite sonication
with glass bead lysis (SIGMA – 150:212 microns). The methodology was assayed
using 1  107 cell culture tachyzoites/mL and is described in detail in the Section 2.
Toxoplasma lysate
antigen production
Protocols for tachyzoite lysis
Sonication Glass beads
Lysis/period 10 cycles/5 min 8 cycles/4 min
Lysis intervals (min) 2 2
% Lysis 80–90 100
5 10 15 20 25 30
0.0
0.5
1.0
1st th th th th th th
T. gondii tachyzoite culture passages
EL
IS
A 
(A
49
2 
nm
)
Fig. 3. Immunological reactivity determined by ELISA using TLA (2 lg/mL) as
antigen produced from culture tachyzoites collected at the 1st, 5th, 10th, 15th,
20th, 25th and 30th Vero cell culture passage in serum free-medium. The results
represent the mean value of the absorbance of each serum sample at an optical
density of 492 nm (ELISA A492 nm) obtained from: 10 sera from chronically
infected patients (hollow circles); 10 sera from normal individuals without
toxoplasmosis (hollow squares); three pooled positive mouse sera (full circles);
and three pooled negative mouse sera (full squares) ±SE.
468 T.A. da Costa-Silva et al. / Experimental Parasitology 130 (2012) 463–469der given culture conditions (Hughes et al., 1986). For this purpose,
this study evaluated whether tachyzoites growing in Vero cell
maintained in VP SFM AGT medium, after many passages, are able
to maintain the same antigenic proprieties as those maintained in
experimental mice. The results showed no difference between
tachyzoites from infections in mice or cell cultures. The optimiza-
tion of production of T. gondii in Vero cells in serum-free medium
was successful and demonstrated that this antigen is able to detect
IgG antibodies anti-T. gondii maintaining the immunogenic and
antigenicity capacity after 30 passages.
The best amount of harvested tachyzoites in Vero cell cultures
was 2.1  107 after 7 days post-infection, which used 1.5  106
parasites as inoculum. These results showed that the infection in
Vero cultivated in serum-free medium was successful in propagat-
ing the parasite in vitro for many passages without any loss of
infectivity or decrease of the rate of multiplication.
Regarding the viability of tachyzoites in various passages in cell
cultures, our data are in agreement with other studies showing
that tachyzoites produced by serial passage in HeLa cell cultures
had acceptable viability but did not signiﬁcantly differ in low and
high pass harvests (Ashburn et al., 2000). Thus, the parasites could
be used both from early and later pass numbers, conﬁrming the
diagnostic usefulness of the tachyzoites produced.
One of our main questions was to know whether in several con-
tinued passages, immunogenic progressive loss could occur. The
nucleotide sequences studied were the same between the different
passages, which could mean no change in its viability in the lysate
antigen.
Although these results are promising for cell cultures to replace
animal culture in the routine production of tachyzoites, particular
pitfalls should be noted for all procedures used in cell cultures.
Strict protocols should be followed to prevent contamination and
aseptic techniques in class II cabinets. Stock cell cultures should
be maintained separately from infected cell lines. A liquid nitrogenstorage system is required to restart the process when there is con-
tamination or a complete failure of the cell-culture system to pro-
duce tachyzoites (Harmer et al., 1996).
Finally this study is in agreement with others that showed that
antigen production by cell culture has clear ethical advantages and
economic beneﬁts (Hughes et al., 1986; Ashburn et al., 2000).
Moreover, the use of culture media formulated without any human
or animal derived components, designed for serum-free growth of
cell lines successfully produced tachyzoites.
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